Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

Michail S. Lionakis(National Institutes of Health), Kieron Dunleavy(National Institutes of Health), Mark Roschewski(National Institutes of Health), Brigitte C. Widemann(National Institutes of Health), John A. Butman(National Institutes of Health Clinical Center), Roland Schmitz(National Institutes of Health), Yandan Yang(National Institutes of Health), Diane E. Cole(National Institutes of Health), Christopher Melani(National Institutes of Health), Christine S. Higham(National Institutes of Health), Jigar V. Desai(National Institutes of Health), Michele Ceribelli(National Institutes of Health), Lu Chen(National Institutes of Health), Craig J. Thomas(National Institutes of Health), Richard F. Little(National Institutes of Health), Juan Gea‐Banacloche(National Institutes of Health), Sucharita Bhaumik(National Institutes of Health), Maryalice Stetler‐Stevenson(National Institutes of Health), Stefania Pittaluga(National Institutes of Health), Elaine S. Jaffe(National Institutes of Health), John D. Heiss(National Institutes of Health), Nicole Lucas(National Institutes of Health), Seth M. Steinberg(National Institutes of Health), Louis M. Staudt(National Institutes of Health), Wyndham H. Wilson(National Institutes of Health)
Cancer Cell
May 25, 2017
Cited by 494Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis